Alterity Therapeutics (ATHE) Receivables (2017 - 2018)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Alterity Therapeutics (ATHE) has 2 years of Receivables data on record, last reported at $2.4 million in Q2 2018.

• For Q2 2018, Receivables rose 4.65% year-over-year to $2.4 million; the TTM value through Jun 2018 reached $2.4 million, up 4.65%, while the annual FY2018 figure was $2.4 million, 4.26% up from the prior year.
• Receivables reached $2.4 million in Q2 2018 per ATHE's latest filing, up from $2.3 million in the prior quarter.
• Across five years, Receivables topped out at $2.4 million in Q2 2018 and bottomed at $2.3 million in Q2 2017.

Peer Comparison